Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy

Livesey E, Cortina Borja M, Sharif K, Alizai N, McClean P, Kelly D et al (2009) Epidemiology of biliary atresia in England and Wales (1999–2006). Arch Dis Child 94:F451–F455

Chardot C, Carton M, Spire-Bendelac N, Le Pommelet C, Golmard JL, Auvert B (1999) Epidemiology of biliary atresia in France: a national study 1986–96. J Hepatol 31:1006–1013

Yoon PW, Bresee JS, Olney RS, James LM, Khoury MJ (1997) Epidemiology of biliary atresia: a population-based study. Pediatrics 99:376–382

Lin YC, Chang MH, Liao SF, Wu JF, Ni YH, Tiao MM et al (2011) Decreasing rate of biliary atresia in Taiwan: a survey, 2004–2009. Pediatrics 128:e530–e536

Zani A, Quaglia A, Hadzic N, Zuckerman M, Davenport M (2015) Cytomegalovirus-associated biliary atresia: an aetiological and prognostic subgroup. J Pediatr Surg. doi: 10.1016/j.jpedsurg.2015.03.001 (epub ahead of print)

Hartley JL, Davenport M, Kelly DA (2009) Biliary atresia. Lancet 374(9702):1704–1713

Caponcelli E, Knisely AS, Davenport M (2008) Cystic biliary atresia: an etiologic and prognostic subgroup. J Pediatr Surg 43:1619–1624

Davenport M, Tizzard SA, Underhill J, Mieli-Vergani G, Portmann B, Hadzic N (2006) The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr 149:393–400

Karrer FM, Lilly JR (1985) Corticosteroid therapy in biliary atresia. J Pediatr Surg 20:693–695

Miner PB Jr, Gaito JM (1979) Bile flow in response to pharmacologic agents. Hepatic DNA as a reference standard. Biochem Pharmacol 28:1063–1066

Miner PB Jr, Sutherland E, Simon FR (1980) Regulation of hepatic sodium plus potassium-activated adenosine triphosphatase activity by glucocorticoids in the rat. Gastroenterol 79:212–221

Davenport M, Gonde C, Redkar R, Koukoulis G, Tredger M, Mieli-Vergani G et al (2001) Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 36:1017–1025

Mack CL, Falta MT, Sullivan AK, Karrer F, Sokol RJ, Freed BM et al (2007) Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterol 133:278–287

Hill R, Quaglia A, Hussain M, Hadzic N, Mieli-Vergani G, Vergani D et al (2015) Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome. J Pediatr Surg 50:1297–1303

Narayanaswamy B, Gonde C, Tredger JM, Hussain M, Vergani D, Davenport M (2007) Serial circulating markers of inflammation in biliary atresia—evolution of the post-operative inflammatory process. Hepatol 46:180–187

Kasai M, Suzuki H, Ohashi E, Ohi R, Chiba T, Okamoto A (1978) Technique and results of operative management of biliary atresia. World J Surg 2(5):571–579

Muraji T, Higashimoto Y (1997) The improved outlook for biliary atresia with corticosteroid therapy. J Pediatr Surg 32:1103–1106

Meyers RL, Book LS, O’Gorman MA, Jackson WD, Black RE, Johnson DG et al (2003) High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 38:406–411

Stringer MD, Davison SM, Rajwal SR, McClean P (2007) Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. J Pediatr Surg 42:1324–1328

Escobar MA, Jay CL, Brooks RM, West KW, Rescorla FJ, Molleston JP et al (2006) Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 41:99–103

Kobayashi H, Yamataka A, Koga H, Okazaki T, Tamura T et al (2005) Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg 40:327–330

Petersen C, Harder D, Melter M, Becker T, Wasielewski RV, Leonhardt J et al (2008) Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 103:712–719

Shimadera S, Iwai N, Deguchi E, Kimura O, Fumino S, Ono S (2007) The significance of steroid therapy after hepatoportoenterostomy in infants with biliary atresia. Eur J Pediatr Surg 17:100–103

Dong R, Song Z, Chen G, Zheng S, Xiao XM (2013) Improved outcome of biliary atresia with postoperative high-dose steroid. Gastroenterology Res Pract 2013:902431

Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N (2007) Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatol 46:1821–1827

Davenport M, Parsons C, Tizzard S, Hadzic N (2013) Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol 59:1054–1058

Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS et al (2014) Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA 311:1750–1759

Japanese Biliary Atresia Society, Nio M, Muraji T (2013) Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia. Pediatr Surg Int 29:1091–1095

Lao OB, Larison C, Garrison M, Healey PJ, Goldin AB (2010) Steroid use after the Kasai procedure for biliary atresia. Am J Surg 199(5):680–684

Muraji T, Nio M, Ohhama Y, Hashimoto T, Iwanaka T, Takamatsu H et al (2004) Postoperative corticosteroid therapy for bile drainage in biliary atresia-a nationwide survey. J Pediatr Surg 39:1803–1805

Sarkhy A, Schreiber RA, Milner RA, Barker CC (2011) Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? Systematic review and meta-analysis. Can J Gastroenterol 25:440–444

Zhang D, Yang HY, Jia J, Zhao G, Yue M, Wang JX (2014) Postoperative steroids after Kasai portoenterostomy for biliary atresia: a meta-analysis. Int J Surg 12:1203–1209

Chen Y, Nah SA, Chiang L, Krishnaswamy G, Low Y (2015) Postoperative steroid therapy for biliary atresia: systematic review and meta-analysis. J Pediatr Surg. doi: 10.1016/j.jpedsurg.2015.05.016 (epub ahead of print)

Noordzij M, Dekker FW, Zoccali C, Jager KJ (2011) Sample size calculations: basic principles and common pitfalls. Nephron Clin Pract 118:c319–c323

Yeh TF, Lin YJ, Lin HC et al (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350:1304–1313

Stark AR, Carlo WA, Tyson JE et al (2001) Adverse effects of early dexamethasone in extremely-low-birth-weight infants. N Engl J Med 2001 344:95–101

Davenport M, Caponcelli E, Livesey E, Hadzic N, Howard E (2008) Surgical outcome in biliary atresia: etiology affects the influence of age at surgery. Ann Surg 247:694–698